'Vascular events' presentation slideshows

Farzad Hadaegh , MD, Professor of Internal Medicine & Endocrinology

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence. Farzad Hadaegh , MD, Professor of Internal Medicine & Endocrinology Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences

1.5k views • 116 slides

The Client with Alterations in Cardiac Output

1.61k views • 104 slides

Depression in the Medically Ill

Depression in the Medically Ill. Ira Lesser, M.D. Chair, Department of Psychiatry Harbor-UCLA Medical Center Professor, Department of Psychiatry and Biobehavioral Sciences Geffen School of Medicine at UCLA. Disclosures. Grant support National Institute for Mental Health

1.23k views • 66 slides

PATHOPHYSIOLOGY OF CEREBRAL ISCHEMIA

2.47k views • 58 slides

Drugs affecting coagulation

Drugs affecting coagulation. Applied Clinical Sciences Lecture Programme. Dr Cathy Armstrong Anaesthetic SpR & Clinical Fellow in Undergraduate Medical Education May 2010. Aims and objectives. To understand the principles of haemostasis & clotting

1.79k views • 48 slides

Medical Management and Risk Factor Modification SVS clinical research priorities meeting 2011

Medical Management and Risk Factor Modification SVS clinical research priorities meeting 2011. Peter Henke, MD University of Michigan. Overview. Epidemiology of atherosclerotic/-atherothrombotic manifestations in vascular surgical patients

581 views • 48 slides

Recent Clinical Trial Results - A Critique

Recent Clinical Trial Results - A Critique. William Cushman, MD Professor, Preventive Medicine and Medicine University of Tennessee College of Medicine Chief, Preventive Medicine Memphis VA Medical Center. How low should BP be treated with antihypertensive medications?.

598 views • 44 slides

589 views • 41 slides

T2DM: NICE Guidelines

794 views • 40 slides

Sleep Matters for Aviation

Sleep Matters for Aviation . TUG March 19, 2014 . Dr. Carol Ash Corporate Director Sleep Medicine Meridian Health . Make a difference. . What would you do? . What did I do?. A story of Purpose. Corey and Jennifer Briest. ? Bravest Family in America - YouTube.

532 views • 36 slides

959 views • 32 slides

Update on Anti-platelets

Update on Anti-platelets. Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th , 2009. Primary Stroke Prevention. Primary Vascular Disease Prevention Primary Prevention Trials Meta-Analysis Lancet 2009; 373:1849-60. Meta-analysis for serious vascular events

460 views • 30 slides

Canadian Cardiovascular Society Antiplatelet Guidelines

Canadian Cardiovascular Society Antiplatelet Guidelines. ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Working Group: Neesh Pannu , MD, SM, FRCP; Alan D. Bell, MD, CCFP. Objectives.

560 views • 29 slides

Juvenile Rheumatoid Arthritis Clinical Overview

1.07k views • 18 slides

ESPS-2: European Stroke Prevention Study

Multicentre, randomized, double-blind, placebo-controlled trial 6,602 patients randomized within 3 months of qualifying event (TIA or stroke) Treatment and follow-up time: 2 years Visits at 1 month and 3 months, then at 3-month intervals. ESPS-2: European Stroke Prevention Study .

892 views • 16 slides

Clinton Memorial Hospital

482 views • 15 slides

Causality Matters

Causality Matters. Some examples from clinical development. John Adler, Head of Biometrics & Information Science for Cardiovascular and Metabolics , AstraZeneca FMS Dec 2, 2013. Overview . Two examples from Clinical development.

337 views • 15 slides

309 views • 14 slides

HYVET Trial

HYVET Trial. The Hypertension in the Very Elderly Trial (HYVET). HYVET Trial. HYVET Trial. Presented at ACC 2008 in Chicago Presented by Dr. Nigel S. Beckett. Copyleft Clinical Trial Results. You Must Redistribute Slides. HYVET Trial: Background.

1.23k views • 11 slides

HPS2-THRIVE: Effect of ERN/LRPT on MAJOR VASCULAR EVENTS

HPS2-THRIVE: Effect of ERN/LRPT on MAJOR VASCULAR EVENTS. 1. 2. 3. 4. Years of follow-up. ACC 2013. HPS2-THRIVE Collaborative Group. HPS2-THRIVE: Effect of ERN/LRPT on MAJOR VASCULAR EVENTS. ACC 2013. HPS2-THRIVE Collaborative Group.

141 views • 3 slides